GeneLink, Inc.
GNLKQ
$0.00
$0.000.00%
| 09/30/2013 | 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | |
|---|---|---|---|---|---|
| Revenue | -33.64% | -42.79% | -56.50% | -54.40% | -52.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -33.64% | -42.79% | -56.50% | -54.40% | -52.85% |
| Cost of Revenue | -19.07% | 4.63% | 4.33% | -3.65% | -23.96% |
| Gross Profit | -55.81% | -83.22% | -95.02% | -84.24% | -70.12% |
| SG&A Expenses | -49.71% | -55.13% | -55.67% | -44.90% | -23.82% |
| Depreciation & Amortization | -30.91% | -53.20% | -51.03% | -48.70% | -45.29% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.12% | -40.73% | -41.28% | -34.15% | -22.14% |
| Operating Income | 46.23% | 38.99% | 25.15% | 7.55% | -40.18% |
| Income Before Tax | 35.95% | 23.52% | 1.31% | 20.32% | -14.28% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 35.95% | 23.52% | 1.31% | 20.32% | -14.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.95% | 23.52% | 1.31% | 20.32% | -14.28% |
| EBIT | 46.23% | 38.99% | 25.15% | 7.55% | -40.18% |
| EBITDA | 47.32% | 39.82% | 25.59% | 7.03% | -44.37% |
| EPS Basic | 48.21% | 32.94% | 13.95% | 32.20% | 5.62% |
| Normalized Basic EPS | 53.23% | 43.65% | 31.54% | 18.75% | -11.71% |
| EPS Diluted | 48.21% | 32.94% | 13.95% | 32.20% | 5.62% |
| Normalized Diluted EPS | 53.23% | 43.65% | 31.54% | 18.75% | -11.71% |
| Average Basic Shares Outstanding | 24.46% | 18.91% | 16.95% | 17.97% | 20.68% |
| Average Diluted Shares Outstanding | 24.46% | 18.91% | 16.95% | 17.97% | 20.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
